Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

The U.S. Food and Drug Administration (FDA) announced on Friday, after market close, that it is investigating the death of an ...

Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

William Blair has named Brent Gledhill as CEO. He will be succeeding John Ettelson, who has been appointed William Blair’s chairman. Gledhill joined William Blair as an investment banker in ...

Sarepta Therapeutics failed to win the European drug regulator's backing for its muscle disorder gene therapy on Friday, as ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

He was preceded in death by sons William Blair III and Jordan Blair. Advertisement “He was a Renaissance man,” said Gregory Jordan, a nephew.

The William Blair venture that utilizes InvestCloud's cloud-based technology was created to give advisors access to a suite of proprietary software aimed at streamlining day-to-day operations and ...